Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

NLRB Issues Final Rule on Joint-Employer Status

Client Alert

On October 26, 2023, the National Labor Relations Board (NLRB) issued its final rule on determining joint-employer status, departing from its prior 2020 standard. The final rule provides that two or more entities may be considered “joint employers” if each entity has an employment relationship with employees and if the entities share or codetermine one or more employees’ essential terms and conditions of employment. The final rule goes into effect on December 26, 2023, and will only be applied to cases filed after the effective date. 

The NLRB provides that essential terms and conditions of employment may include: 

  • Wages, benefits, and other compensation, 
  • Hours of work and scheduling, 
  • The assignment of duties to be performed, 
  • The supervision of the performance of duties, 
  • Work rules and directions governing the manner, means, and methods of the performance of duties and the grounds for discipline, 
  • The tenure of employment, including hiring and discharge, and 
  • Working conditions related to the safety and health of employees. 

The final rule broadens the standard for employers to be considered “joint” under the National Labor Relations Act (NLRA). The final rule considers the alleged joint employers’ authority to control essential terms and conditions of employment but does not consider whether or not such control was exercised, nor whether any exercise of control is direct or indirect. Thus, mere indirect or reserved control may be sufficient to be deemed a joint employer under the NLRA. 

Alternatively, the prior 2020 standard required a higher threshold for joint-employer status. Under the prior rule, substantial direct and immediate control over essential terms and conditions was required. Hence, the 2020 rule made it easier for actual joint employers to avoid joint-employer status. However, the NLRB has rescinded and replaced the 2020 standard with a new, broadened approach. 

In addressing how this new standard affects particular kinds of businesses (e.g., franchises, temp agencies, staffing firms, etc.), the NLRB provides that “[t]he nature of the business-to-business relationship is incidental to the analysis established by the final rule.” Specifically, the NLRB states that not all franchisors and their franchisees will be deemed joint employers. Further, not every staffing or temporary agency and their client-employers will be considered joint employers. Rather, in determining whether two employers meet the standard, the NLRB will apply a fact-specific analysis in each case. 

In response to the final rule, employers should evaluate their relationships with any third-party entities to determine whether they could be deemed joint employers under the NLRA. 

Should you have any questions concerning the final rule or its implications, please contact BMD Member John Childs at jnchilds@bmdllc.com or Partner and Co-Chair of BMD's Labor & Employment Group, Bryan Meek, at bmeek@bmdllc.com.


Ohio Board of Pharmacy Update: Key Regulatory Changes and Proposals You Need to Know

The Ohio Board of Pharmacy (BOP) has rescinded certain OAC rules (OAC 4729:5-18-01 through 4729:5-18-06), removing regulations on office-based opioid treatment (OBOT) clinics. The rescissions took effect on June 3, 2024. The BOP also published a new rule, OAC 4729:8-5-01, which sets explicit reporting guidelines for licensed dispensaries and became effective on June 7, 2024.

LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.